Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2022 | Anticytokine autoantibodies: Autoimmunity trespassing on antimicrobial immunity | ARISTINE CHENG ; Holland, Steven M | The Journal of allergy and clinical immunology | 1 | 0 | |
2018 | Application of a fluorescent marker with quantitative bioburden methods to assess cleanliness | Hung I.-C.; Chang H.-Y.; ARISTINE CHENG ; Chen A.-C.; Ting L.; Chen M.-W.; Lai Y.-H.; Sheng W.-H. | Infection Control and Hospital Epidemiology | 8 | 7 | |
2012 | Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan | Lai C.-C.; Chu C.-C.; Wang C.-Y.; Tsai H.-Y.; ARISTINE CHENG ; Lee Y.-C.; Huang Y.-T.; Liao C.-H.; Hsueh P.-R. | International Journal of Antimicrobial Agents | 23 | 22 | |
2012 | Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010 | Tsai H.-Y.; ARISTINE CHENG ; Liu C.-Y.; Huang Y.-T.; Lee Y.-C.; Liao C.-H.; Hsueh P.-R. | European Journal of Clinical Microbiology and Infectious Diseases | 10 | 7 | |
2013 | Bacteremia caused by Pantoea agglomerans at a medical center in Taiwan, 2000-2010 | ARISTINE CHENG ; Liu C.-Y.; Tsai H.-Y.; Hsu M.-S.; Yang C.-J.; Huang Y.-T.; Liao C.-H.; Hsueh P.-R. | Journal of Microbiology, Immunology and Infection | 35 | 36 | |
2017 | Central line-associated bloodstream infections among critically-ill patients in the era of bundle care | Lin K.-Y.; ARISTINE CHENG ; Chang Y.-C.; Hung M.-C.; Wang J.-T.; Sheng W.-H.; Hseuh P.-R.; Chen Y.-C.; Chang S.-C. | Journal of Microbiology, Immunology and Infection | 31 | 29 | |
2021 | Chitosan-based hydrogels to treat hydrofluoric acid burns and prevent infection | Huang S.-W.; Yeh F.-C.; Ji Y.-R.; Su Y.-F.; Su Y.-S.; Chiang M.-H.; Tzeng S.-C.; Fu C.-Y.; ARISTINE CHENG ; Wang Y.-C.; Lee Y.-T. | Drug Delivery and Translational Research | 2 | 3 | |
2015 | Cholelithiasis and nephrolithiasis in HIV-positive patients in the era of combination antiretroviral therapy | Lin K.-Y.; Liao S.-H.; Liu W.-C.; ARISTINE CHENG ; Lin S.-W.; Chang S.-Y.; Tsai M.-S.; Kuo C.-H.; Wu M.-R.; Wang H.-P.; Hung C.-C.; Chang S.-C. | PLoS ONE | 12 | 9 | |
2019 | Chronic disseminated candidiasis manifesting as hepatosplenic abscesses among patients with hematological malignancies | Chen C.-Y.; ARISTINE CHENG ; Tien F.-M.; Lee P.-C.; Tien H.-F.; Sheng W.-H.; Chen Y.-C. | BMC Infectious Diseases | 7 | 6 | |
2013 | Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia | Chen C.-Y.; ARISTINE CHENG ; Huang S.-Y.; Sheng W.-H.; Liu J.-H.; Ko B.-S.; Yao M.; Chou W.-C.; Lin H.-C.; Chen Y.-C.; Tsay W.; Tang J.-L.; Chang S.-C.; Tien H.-F. | PLoS ONE | 33 | 30 | |
2013 | Clinical and pathological characteristics of mycobacterial tenosynovitis and arthritis | Hsiao C.-H.; ARISTINE CHENG ; Huang Y.-T.; Liao C.-H.; Hsueh P.-R. | Infection | 22 | 21 | |
2011 | Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies | Chen C.-Y.; Sheng W.-H.; ARISTINE CHENG ; Tsay W.; Huang S.-Y.; Tang J.-L.; Chen Y.-C.; Wang J.-Y.; Tien H.-F.; Chang S.-C. | BMC Infectious Diseases | 32 | 28 | |
2012 | CNS infections caused by Mycobacterium abscessus complex: clinical features and antimicrobial susceptibilities of isolates | Lee M.-R.; ARISTINE CHENG ; Lee Y.-C.; Yang C.-Y.; Lai C.-C.; Huang Y.-T.; Ho C.-C.; Wang H.-C.; Yu C.-J.; Hsueh P.-R. | Journal of Antimicrobial Chemotherapy | 42 | 41 | |
2018 | Comparable serologic responses to 2 different combinations of inactivated hepatitis A virus vaccines in HIV-positive patients during an acute hepatitis A outbreak in Taiwan | Lin K.-Y.; Hsieh S.-M.; Sheng W.-H.; Lo Y.-C.; Chuang Y.-C.; ARISTINE CHENG ; Pan S.-C.; Chen G.-J.; Sun H.-Y.; Hung C.-C.; Chang S.-C. | Journal of Infectious Diseases | 5 | 5 | |
2011 | Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU | Sheng W.-H.; Wang J.-T.; Li S.-Y.; Lin Y.-C.; ARISTINE CHENG ; Chen Y.-C.; Chang S.-C. | Diagnostic Microbiology and Infectious Disease | 70 | 65 | |
2015 | Comparative in vitro antimicrobial susceptibility and synergistic activity of antimicrobial combinations against Helicobacter pylori isolates in Taiwan | ARISTINE CHENG ; Sheng W.-H.; Liou J.-M.; Wang H.-P.; Wu M.-S.; Lin J.-T.; Chang S.-C. | Journal of Microbiology, Immunology and Infection | 26 | 21 | |
2020 | Comparing the utilities of different multilocus sequence typing schemes for identifying outbreak strains of mycobacterium abscessus subsp. Massiliense | ARISTINE CHENG ; Sun H.-Y.; Tsai Y.-T.; Chang S.-Y.; Wu U.-I.; Hsueh P.-R.; Sheng W.-H.; Chen Y.-C.; Chang S.-C. | Journal of Clinical Microbiology | 1 | 2 | |
2015 | Comparing visual inspection, aerobic colony counts, and adenosine triphosphate bioluminescence assay for evaluating surface cleanliness at a medical center | Huang Y.-S.; Chen Y.-C.; Chen M.-L.; ARISTINE CHENG ; Hung I.-C.; Wang J.-T.; Sheng W.-H.; Chang S.-C. | American Journal of Infection Control | 34 | 32 | |
2019 | Concerns about the Association between Poor Clinical Outcomes and the Minimum Inhibitory Concentrations Determined by Etest | ARISTINE CHENG ; Chuang Y.-C. | Clinical Infectious Diseases | 0 | 0 | |
2022 | Correction to: Chitosan‑based hydrogels to treat hydrofluoric acid burns and prevent infection | Huang, Shu-Wei; Yeh, Fang-Ching; Ji, You-Ren; Su, Ying-Fu; Su, Ying-Shih; Chiang, Ming-Hsien; Tzeng, Shian-Chiuan; Fu, Chien-Yao; ARISTINE CHENG ; Wang, Yung-Chih; Lee, Yi-Tzu | Drug delivery and translational research | 0 | 0 | |